Cerapedics, a developer of ortho-biological technology, is dedicated to offering bone graft substitutes for use in spinal fusion surgery and other orthopedic procedures. The company's technology centers on the creation and commercialization of innovative biologic products that integrate a small peptide as an attachment factor to catalyze the natural bone healing process. This empowers physicians to facilitate safer and more predictable bone formation compared to conventional bone growth factors available in the market.
Revelation Partners, KCK MedTech, Miraki Innovation, OrbiMed, KCK Group, NGN Capital.